<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="en" article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molecules</journal-id>
      <journal-title>Molecules</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molecules</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molecules</abbrev-journal-title>
      <issn pub-type="epub">1420-3049</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/molecules180910146</article-id>
      <article-id pub-id-type="publisher-id">molecules-18-10146</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sinulariolide Induced Hepatocellular Carcinoma Apoptosis through Activation of Mitochondrial-Related Apoptotic and PERK/eIF2&#x3B1;/ATF4/CHOP Pathway</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Yi-Jen</given-names>
          </name>
          <xref rid="af1-molecules-18-10146" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Su</surname>
            <given-names>Jui-Hsin</given-names>
          </name>
          <xref rid="af2-molecules-18-10146" ref-type="aff">2</xref>
          <xref rid="fn1-molecules-18-10146" ref-type="fn">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsao</surname>
            <given-names>Chia-Yu</given-names>
          </name>
          <xref rid="af3-molecules-18-10146" ref-type="aff">3</xref>
          <xref rid="fn1-molecules-18-10146" ref-type="fn">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hung</surname>
            <given-names>Chun-Tzu</given-names>
          </name>
          <xref rid="af4-molecules-18-10146" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chao</surname>
            <given-names>Hsiang-Hao</given-names>
          </name>
          <xref rid="af5-molecules-18-10146" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Jen-Jie</given-names>
          </name>
          <xref rid="af6-molecules-18-10146" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liao</surname>
            <given-names>Ming-Hui</given-names>
          </name>
          <xref rid="af6-molecules-18-10146" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Zih-Yan</given-names>
          </name>
          <xref rid="af7-molecules-18-10146" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Han Hisang</given-names>
          </name>
          <xref rid="af8-molecules-18-10146" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsai</surname>
            <given-names>Feng-Jen</given-names>
          </name>
          <xref rid="af8-molecules-18-10146" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weng</surname>
            <given-names>Shun-Hsiang</given-names>
          </name>
          <xref rid="af9-molecules-18-10146" ref-type="aff">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Yu-Jen</given-names>
          </name>
          <xref rid="af8-molecules-18-10146" ref-type="aff">8</xref>
          <xref rid="c1-molecules-18-10146" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
	  <aff id="af1-molecules-18-10146"><label>1</label>Department of Physical Medicine and Rehabilitation, Kaohsiung Medical University Hospital, Kaohsiung 80761, Taiwan; E-Mail: <email>chernkmu@gmail.com</email></aff>
      <aff id="af2-molecules-18-10146"><label>2</label>National Museum of Marine Biology and Aquarium, Pingtung 94450, Taiwan; E-Mail: <email>x2219@nmmba.gov.tw</email></aff>
      <aff id="af3-molecules-18-10146"><label>3</label>Graduate Institute of Animal Vaccine Technology, National Pingtung University of Science and Technology, Pingtung 91202, Taiwan; E-Mail: <email>d00086dog@yahoo.com.tw</email></aff>
      <aff id="af4-molecules-18-10146"><label>4</label>Department of Ophthalmology, Yuan&#x2019;s General Hospital, Kaohsiung 80249, Taiwan; E-Mail: <email>hygia1109@gmail.com</email></aff>
      <aff id="af5-molecules-18-10146"><label>5</label>English Division of the Second Faculty of Medicine, Medical University of Warsaw, Warsaw 02091, Poland; E-Mail: <email>chaohsianghao@gmail.com</email></aff>
      <aff id="af6-molecules-18-10146"><label>6</label>Graduate Institute of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 91202, Taiwan; E-Mails: <email>q87634@yahoo.com.tw</email> (J.-J.L.); <email>mhliao@mail.npust.edu.tw</email> (M.-H.L.)</aff>
      <aff id="af7-molecules-18-10146"><label>7</label>Graduate Institute of Food Science, National Pingtung University of Science and Technology, Pingtung 91202, Taiwan; E-Mail: <email>gini0307@yahoo.com.tw</email></aff>
      <aff id="af8-molecules-18-10146"><label>8</label>Department of Beauty Science, Meiho University, Pingtung 91202, Taiwan; E-Mails: <email>hhuang.adsl@msa.hinet.net</email> (H.H.H.); <email>x00002036@meiho.edu.tw (F.-J.T.)</email></aff>
      <aff id="af9-molecules-18-10146"><label>9</label>Department of Hospitality Management, Meiho University, Pingtung 91202, Taiwan; E-Mail: <email>x00009520@meiho.edu.tw</email></aff>
      <author-notes>
        <fn id="fn1-molecules-18-10146">
          <label>&#x2020;</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
        <corresp id="c1-molecules-18-10146"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>wyr924@ms24.hinet.net</email> or <email>x00002180@meiho.edu.tw</email>; Tel.: +886-8-779-9821 (ext. 8613); Fax: +886-8-779-7821.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>08</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="collection"><month>09</month>
		<year>2013</year>
      </pub-date>
      <volume>18</volume>
      <issue>9</issue>
      <fpage>10146</fpage>
      <lpage>10161</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>07</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>08</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>08</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#x000A9; 2013 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p> Sinulariolide, an active compound isolated from the cultured soft coral <italic>Sinularia flexibilis</italic>, has potent anti-microbial and anti-tumorigenesis effects towards melanoma and bladder cancer cells. In this study, we investigated the effects of sinulariolide on hepatocellular carcinoma (HCC) cell growth and protein expression. Sinulariolide suppressed the proliferation and colony formation of HCC HA22T cells in a dose-dependent manner and induced both early and late apoptosis according to flow cytometry, Annexin V/PI stain and TUNEL/DAPI stain analyses. A mechanistic analysis demonstrated that sinulariolide-induced apoptosis was activated through a mitochondria-related pathway, showing up-regulation of Bax, Bad and AIF, and down- regulation of Bcl-2, Bcl-xL, MCl-1 and p-Bad. Sinulariolide treatment led to loss of the mitochondrial membrane potential, release of mitochondrial cytochrome c to the cytosol, and activation of both caspase-9 and caspase-3. Sinulariolide-induced apoptosis was significantly blocked by the caspase inhibitors Z-VAD-FMK and Z-DEVD-FMK. The increased expression of cleaved PARP also suggested that caspase-independent apoptotic pathway was involved. In the western blotting; the elevation of ER chaperones GRP78; GRP94; and CALR; as well as up-regulations of PERK/eIF2&#x3B1;/ATF4/CHOP; and diminished cell death with pre-treatment of eIF2&#x3B1; phosphatase inhibitor; salubrinal; implicated the involvement of ER stress-mediated PERK/eIF2&#x3B1;/ATF4/CHOP apoptotic pathway following sinulariolide treatment in hepatoma cells. The current study suggested sinulariolide-induced hepatoma cell cytotoxicity involved multiple apoptotic signal pathways. This may implicate that sinulariolide is a potential compound for the treatment of hepatocellular carcinoma.</p>
      </abstract>
      <kwd-group>
        <kwd>hepatocellular carcinoma</kwd>
        <kwd>sinulariolide</kwd>
        <kwd>mitochondrial</kwd>
        <kwd>PERK/eIF2&#x3B1;/ATF4/CHOP</kwd>
        <kwd>apoptosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>1. Introduction</title>
      <p>Hepatocellular carcinoma (HCC), which has been reported as the most common primary malignant liver tumor, and is the third leading cause of cancer death worldwide, has received much public health attention [<xref ref-type="bibr" rid="B1-molecules-18-10146">1</xref>]. HCC presents as an aggressive tumor type with a median survival following diagnosis of approximately 6 to 20 months [<xref ref-type="bibr" rid="B2-molecules-18-10146">2</xref>]. Standard treatment options for HCC include surgical resection, liver transplantation, transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radiofrequency ablation (RFA), and targeted therapy, depending on cancer stages and suitable candidates [<xref ref-type="bibr" rid="B3-molecules-18-10146">3</xref>]. Surgical eligibility and side effects of chemotherapy agents remain as major concerns of these aggressive treatment options [<xref ref-type="bibr" rid="B4-molecules-18-10146">4</xref>]. Therefore, agents with anti-cancer potentials and fewer side effects are more clinically preferable for cancer treatment.</p>
      <p>The induction of apoptosis critically benefits cancer therapy development [<xref ref-type="bibr" rid="B5-molecules-18-10146">5</xref>]. The apoptotic processes can be triggered either via extrinsic pathways by the plasma membrane or intrinsic pathways which are within cells [<xref ref-type="bibr" rid="B6-molecules-18-10146">6</xref>,<xref ref-type="bibr" rid="B7-molecules-18-10146">7</xref>]. Recent studies have shown that intrinsic pathways are initiated by the associations between stress and the endoplasmic reticulum (ER) or mitochondria [<xref ref-type="bibr" rid="B8-molecules-18-10146">8</xref>]. ER is responsible for protein synthesis, protein folding, lipid synthesis and intracellular calcium homeostasis [<xref ref-type="bibr" rid="B9-molecules-18-10146">9</xref>,<xref ref-type="bibr" rid="B10-molecules-18-10146">10</xref>]. </p>
      <p>The abnormality of calcium balance or protein folding in ER may result in ER stress and this subsequently induces self-rescuing or destructive responses in cells. Processes of mitochondrial dysregulation have been demonstrated as major events during apoptosis while the Bcl-2 family, like Bax and Bak, is related to the alteration of mitochondrial membrane potential and the release of mitochondrial apoptotic factors [<xref ref-type="bibr" rid="B11-molecules-18-10146">11</xref>]. Cytochrome <italic>c</italic> freed from the mitochondrial inter-membrane spaces initiates the serial reactions leading to apoptosis. The serial reactions begin with the activation of caspase-9, and further activation of the downstream effector caspase-3; activated caspase-3 then cleaves and activates poly ADP-ribose polymerase (PARP) [<xref ref-type="bibr" rid="B11-molecules-18-10146">11</xref>,<xref ref-type="bibr" rid="B12-molecules-18-10146">12</xref>].</p>
      <p>Recently, many studies have analyzed active compounds from soft coral seeking new therapeutic drug candidates for the inhibition or prevention of cancer development [<xref ref-type="bibr" rid="B13-molecules-18-10146">13</xref>,<xref ref-type="bibr" rid="B14-molecules-18-10146">14</xref>,<xref ref-type="bibr" rid="B15-molecules-18-10146">15</xref>,<xref ref-type="bibr" rid="B16-molecules-18-10146">16</xref>]. Sinulariolide, an active compound isolated from the cultured soft coral <italic>Sinularia flexibilis</italic> [<xref ref-type="bibr" rid="B17-molecules-18-10146">17</xref>] has various biological properties, including anti-microbial and anti-cancer activities, particularly in bladder cancer and melanoma [<xref ref-type="bibr" rid="B18-molecules-18-10146">18</xref>,<xref ref-type="bibr" rid="B19-molecules-18-10146">19</xref>]. In the current research, the effects of sinulariolide on hepatoma cells were evaluated through cell viability, colony formation, flow cytometry, TUNEL/DAPI stain and Annexin V/PI stain analysis. The results indicated that sinulariolide has the apoptosis-inducing ability and the anti-tumor properties on HA22T cells. The potential pathways of apoptosis stimulated by sinulariolide in HCC cells were determined by mitochondrial membrane potential measurement, apoptotic inhibition test and immunoblotting. Crucial data was obtained to reveal the cytotoxic activities and several apoptotic pathways of sinulariolide in HCC cells <italic>in vitro</italic>. Overall, these results could provide valuable information for drug development or potential strategies against human HCC.</p>
    </sec>
    <sec sec-type="results">
      <title>2. Results and Discussion</title>
      <sec>
        <title>2.1. The Cytotoxic Effects of Sinulariolide on Different Hepatocellular Carcinoma Cell Lines</title>
        <p>To explore the potential cytotoxic effect of sinulariolide on the HCC cells, MTT assay and colony formation assay were performed. The cytotoxic effect of sinulariolide on four HCC cell lines (HepG2, Hep3B, HA22T and Huh7 cells) were performed in this study. HCC cells were treated with various concentrations (2, 4, 8, 10 &#x3BC;g/mL) of sinulariolide for 24 h. Sinulariolide treatment clearly reduced cell viability in all HCC cell lines in a dose-dependent manner. The result showed that HA22T and HepG2 cells were more sensitive in response to the treatment of sinulariolide (<xref ref-type="fig" rid="molecules-18-10146-f001">Figure 1</xref>A). The IC<sub>50</sub> values of sinulariolide treatment in four HCC cell lines are shown in <xref ref-type="table" rid="molecules-18-10146-t001">Table 1</xref>.</p>
        <table-wrap id="molecules-18-10146-t001" position="float">
          <object-id pub-id-type="pii">molecules-18-10146-t001_Table 1</object-id>
          <label>Table 1</label>
          <caption>
            <p>IC50 values of sinulariolide treatment in four HCC cell lines.</p>
          </caption>
          <table>
            <thead>
              <tr>
                <th align="center" valign="middle">Cell line</th>
                <th align="center" valign="middle">IC<sub>50</sub> (&#x3BC;g/mL)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center" valign="middle">Huh7</td>
                <td align="center" valign="middle">12.31 &#xB1; 0.25</td>
              </tr>
              <tr>
                <td align="center" valign="middle">HepG2</td>
                <td align="center" valign="middle">10.34 &#xB1; 0.34</td>
              </tr>
              <tr>
                <td align="center" valign="middle">Hep3B</td>
                <td align="center" valign="middle">16.52 &#xB1; 0.13</td>
              </tr>
              <tr>
                <td align="center" valign="middle">HA22T</td>
                <td align="center" valign="middle">8.46 &#xB1; 0.05</td>
              </tr>
            </tbody>
          </table>
		</table-wrap>
        <p>The cell morphology was investigated and compared between control and sinulariolide-treated HA22T and HepG2 cells using the inverted light microscopy. Microscopic observations revealed that HA22T and HepG2 cell population decreased after 10 &#x3BC;g/mL sinulariolide treatment (<xref ref-type="fig" rid="molecules-18-10146-f001">Figure 1</xref>B). In HA22T and HepG2 cells, sinulariolide showed dose-dependent inhibitory effects on the colony formation (<xref ref-type="fig" rid="molecules-18-10146-f001">Figure 1</xref>C). In HA22T cells, the decreased numbers of colonies formed at sinulariolide concentrations of 2, 4, 8 and 10 &#x3BC;g/mL were 20, 31, 56 and 74% respectively. In HepG2 cells, the decreased numbers of colonies formed at sinulariolide concentration of 2, 4, 8 and 10 &#x3BC;g/mL were 16, 18, 45 and 66% respectively. Comparing the HA22T and HepG2 cell lines, HA22T cells were more sensitive to sinulariolide treatment.</p>
		<fig id="molecules-18-10146-f001" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Evaluation of the cell cytotoxicity and colony formation effects of sinulariolide on hepatocellular carcinoma cell lines. (<bold>A</bold>) The viable cell number of different HCC cell lines was dose-dependently suppressed by MTT assay. The results shown are representative of three independent experiments (<sup>#</sup> <italic>p</italic> &lt; 0.05, * <italic>p</italic> &lt; 0.001 compared with the control). HA22T and HepG2 cell lines were more sensitive to sinulariolide treatment. (<bold>B</bold>) The morphological change of HA22T and HepG2 cells upon sinulariolide treatment. Scale bar = 20 &#x3BC;m (<bold>C</bold>) Cells were seeded in six-well plates. After 24 h of incubation, cells were treated with serial concentrations of sinulariolide. The number of colony formation was counted as described in the Experimental section. The results shown are representative of three independent experiments (<sup>#</sup> <italic>p</italic> &lt; 0.05, * <italic>p</italic> &lt; 0.001 compared with the control).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-18-10146-g001.tif"/>
        </fig> 
      </sec>
      <sec>
        <title>2.2. Sinulariolide Induced Apoptosis of HA22T Cells</title>
        <p>To investigate whether sinulariolide induced HA22T cell apoptosis, HA22T cells were treated with sinulariolide and stained with flow cytometry based-annexin V-FITC/PI double staining, and analyzed with flow cytometer. After treatment with 0, 4, 8 and 10 &#x3BC;g/mL of sinulariolide, the presences of early apoptosis/later apoptosis were 0.39%/1.42%, 3.71%/1.75%, 13.4%/9.53% and 12.1%/13.7%, respectively (<xref ref-type="fig" rid="molecules-18-10146-f002">Figure 2</xref>A). These data showed that sinulariolide efficiently induced apoptosis of HA22T cells. To further validate apoptotic effect of sinulariolide on the HA22T cells, annexin V-FITC/PI double staining, Terminal deoxynucleotidyltransferase UTP nick end labeling (TUNEL) and 4&#x2019;,6-diamidino-2-phenyl iodide (DAPI) stained assays were performed. Some massive apoptotic bodies were observed in HA22T cells treated with 10 &#x3BC;g/mL of sinulariolide (<xref ref-type="fig" rid="molecules-18-10146-f002">Figure 2</xref>B,C). Altogether, these results demonstrated that sinulariolide induced both early and late apoptosis in HA22T cells, and the apoptotic effect was dose-dependent.</p>
        <fig id="molecules-18-10146-f002" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Sinulariolide-induced apoptosis of HA22T cells. (<bold>A</bold>) Detection of apoptotic HA22T cells after sinulariolide treatment (0, 4, 8 and 10 &#x3BC;g/mL) by Annexin V- fluoresceinisothiocyanate (FITC)/porpidium iodide (PI) analysis. Sinulariolide induced early and late apoptosis in a dose-dependent manner. Bottom right quadrants, early apoptotic cells; top right quadrants, late apoptotic cells. (<bold>B</bold>) AnnexinV-FITC/PI analyses of apoptotic HA22T cells upon sinulariolide treatment. The HA22T cells were stained by PI (red) and Annexin-V (green) after different concentrations of sinulariolide treatment. (<bold>C</bold>) Detection of apoptotic cells by TUNEL and DAPI staining assay. HA22T cells were treated with sinulariolide at the final concentration of 4, 8 and 10 &#x3BC;g/mL for 24 h. The cells were harvested for TUNEL and DAPI staining as described in the Experimental section. Scale bar = 50 &#x3BC;m.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-18-10146-g002.tif"/>
        </fig>
        <p>We further investigated the effect of sinulariolide on the activation of caspase and PARP cleavage. We examined the PARP, pro-caspase-3, cleaved-caspase-3, pro-caspase-9, cleaved-caspase-9 and pro-caspase-8 by western blotting assay after sinulariolide treatment. In <xref ref-type="fig" rid="molecules-18-10146-f003">Figure 3</xref>A, western blotting result showed decreased expression levels of pro-caspase-3, pro-caspase-8 and pro-caspase-9 in the sinulariolide treated cells. The increased expression level of cleaved-caspase-3, cleaved-caspased-9 and cleaved-PARP (89 kDa proteolytic fragments) after sinulariolide treatment were observed. These results showed that sinulariolide could activate caspase-dependent pathway. Caspase-8 was not changed after sinulariolide treatment (<xref ref-type="fig" rid="molecules-18-10146-f003">Figure 3</xref>A). Sinulariolide also induced caspase-3 and caspase-9 activity (<xref ref-type="fig" rid="molecules-18-10146-f003">Figure 3</xref>B).</p>
        <fig id="molecules-18-10146-f003" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Sinulariolide induced apoptosis through activated caspase cascade pathway. HA22T cells were treated with sinulariolide (0, 2, 4, 8 and 10 &#x3BC;g/mL) for 24 h. (<bold>A</bold>) The detection of mitochondrial related apoptosis proteins were performed by western blotting analysis using specific antibodies as indicated. The results showed the changes of caspase-3, caspase-8, caspase-9, cleaved-caspase-3 and cleaved-caspase-9 expression in HA22T treated with sinulariolide. &#x3B2;-actin was used as the protein loading control. (<bold>B</bold>) Caspase-3 and caspase-9 activities were increased after sinulariolide treatment. The results shown are representative of three independent experiments (<sup>#</sup> <italic>p</italic> &lt; 0.05, * <italic>p</italic> &lt; 0.001 compared with the control). (<bold>C</bold>) HA22T cells were pre-treated with two cell-permeant pan caspase inhibitors, Z-VAD-FMK and Z-DEVD-FMK, before sinulariolide treatment. The cells were then harvested at 24 h and further MTT assay was performed for the evaluation of cell viability. The related cell viabilities were determined from three independent experiments (<sup>#</sup> <italic>p</italic> &lt; 0.05, compared with the control).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-18-10146-g003.tif"/>
        </fig>
        <p>To determine whether sinulariolide induced cell apoptosis through caspase activation, cells were pre-treated with Z-DEVD-FMK (caspase-3 inhibitor) and Z-LEHD-FMK (caspase-9 inhibitor) before sinulariolide treatment. The result showed that pre-treatment with Z-DEVD-FMK and Z-LEHD-FMK significantly inhibited the sinulariolide-induced cell apoptosis (<xref ref-type="fig" rid="molecules-18-10146-f003">Figure 3</xref>C). These data suggested that caspase-3 and caspase-9 were involved in the sinulariolide-induced cell apoptosis in HCC cells.</p>
      </sec>
      <sec>
        <title>2.3. Treatment of Sinulariolide Causes the Mitochondrial Depolarization and Activated the Mitochondrial-Related Apoptotic Pathway in HA22T Cells</title>
        <p>The involvement of changes in mitochondrial membrane potential (&#x394;&#x3A8;m) in the role of mitochondrial-related apoptosis initiation has received growing attention. In this study, we measured the change in mitochondrial membrane potential (&#x394;&#x3A8;m) induced by sinulariolide with JC-1 dye. In the sinulariolide-treated HA22T cells, there were significantly increased green fluorescence signals while reduced red fluorescence signals by fluorescence microscopy, suggesting the loss of &#x394;&#x3A8;m with sinulariolide treatment (<xref ref-type="fig" rid="molecules-18-10146-f004">Figure 4</xref>A).</p>
        <fig id="molecules-18-10146-f004" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Sinulariolide induced mitochondrial membrane depolarization in the HA22T cells. (<bold>A</bold>) Cells were treated as indicated, stained with JC-1 dye, incubated with cells for 20 min at 37 &#xB0;C, 5% CO<sub>2</sub> and imaged under fluorescence microscope at the emission wavelength of 580 nm (red, upper panels) and 530 nm (green, lower panels). Scale bars = 50 &#x3BC;m. (<bold>B</bold>) Western blotting data showed the changes of Bax, Bad, p-Bad, Bcl-2, Bcl-xL, Mcl-1, cytosolic cytochrome <italic>c</italic>, and AIF expression in HA22T cells treated with different concentrations of sinulariolide. &#x3B2;-actin was used as the cytosol marker internal control. GAPDH was used as the mitochondrial marker internal control.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-18-10146-g004.tif"/>
        </fig>
        <p>The involvements of caspase-3 and caspase-9 were demonstrated in the previous section, and these suggested that mitochondrial-related apoptotic pathway plays a critical role in the sinulariolide-induced cell apoptosis. Several mitochondrial-related apoptotic markers were analyzed to verify the assumption, including Bcl-2, Bcl-xL, Mcl-1, Bax, Bad, p-Bad, cytosolic cytochrome <italic>c</italic> and AIF. The results indicated that sinulariolide induced the cell apoptosis through the mitochondrial-related apoptotic pathway (<xref ref-type="fig" rid="molecules-18-10146-f004">Figure 4</xref>B).</p>
      </sec>
      <sec>
        <title>2.4. Treatment of Sinulariolide Induces the Activation of ER Stress Pathway in HA22T Cells</title>
        <p>In the current study, regulations of three ER sensors, IRE1&#x3B1;, PERK, and ATF6 as well as the caspase-12, GRP78, GRP94 and CALR were verified by western blot. The expression of ER chaperones GRP78, GRP94, and CALR after treating sinulariolide was dose-dependently up-regulated. Caspase-12 and IRE1&#x3B1; were not changed after sinulariolide treatment. In addition, the expression levels of p-PERK and p-eIF2&#x3B1; were up-regulated, but PERK and elF2&#x3B1; levels remained unchanged normal forms. The transcription factor ATF4, a downstream signal of PERK-eIF2&#x3B1; pathway, was increased after sinulariolide treatment in HA22T cells. The expression of CHOP, a nuclear protein induced by ER stress, was also increased (<xref ref-type="fig" rid="molecules-18-10146-f005">Figure 5</xref>).</p>
        <fig id="molecules-18-10146-f005" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Exposure to sinulariolide stimulated the factors of ER stress-mediated apoptotic pathway. The changes of ER stress related chaperones including CALR, GRP78 and GRP94 and ER stress sensors IRE1&#x3B1;, caspase-12, PERK, p-PERK, e-IF2&#x3B1;, p-eIF2&#x3B1;, ATF4, ATF6 fragment and CHOP were represented by immunoblotting. &#x3B2;-actin was used as the internal control.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-18-10146-g005.tif"/>
        </fig>
        <p>We further verified the activation of ER stress-mediated apoptotic pathway by performing the ER stress inhibitory test. The HA22T cells were pre-treated with salubrinal, an ER stress inhibitor targeting eIF2&#x3B1; dephosphorylation, before sinulariolide treatment. With 10 &#x3BC;M salubrinal pre-treatment, the cell viability increased from 44% to 68% in the sinulariolide-treated HA22T cells (<xref ref-type="fig" rid="molecules-18-10146-f006">Figure 6</xref>A). Further, TUNEL and DAPI assays were performed to detect DNA fragmentation after sinulariolide-induced apoptosis. The positively TUNEL-stained HA22T cells after sinulariolide treatment was shown in <xref ref-type="fig" rid="molecules-18-10146-f006">Figure 6</xref>B. After pre-treatment with salubrinal, the number of positively TUNEL-stained HA22T cells was significantly decreased. This suggested that ER stress was involved in sinulariolide-induced cell apoptosis.</p>
        <fig id="molecules-18-10146-f006" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Sinulariolide induced HA22T cell apoptosis through ER stress pathways. (<bold>A</bold>) Salubrinal increased cell viability of the sinulariolide-treated HA22T cells. The results shown are representative of three independent experiments (<sup>#</sup> <italic>p</italic> &lt; 0.05, compared with the control). (<bold>B</bold>) The TUNEL and DAPI staining showed a decrease in sinulariolide-induced apoptotic cascade with ER stress inhibitor, salubrinal.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-18-10146-g006.tif"/>
        </fig>
      </sec>
      <sec>
        <title>2.5. Discussion</title>
        <p>The current study demonstrated that sinulariolide has cytotoxic effects and induces apoptosis of the HCC cells. Sinulariolide treatment clearly reduced cell viability on four HCC cell lines (HepG2, Hep3B, HA22T and Huh7 cells) in a dose-dependent manner by MTT assay (<xref ref-type="fig" rid="molecules-18-10146-f001">Figure 1</xref>A). Compared with MTT and colony formation assays, HA22T cells were more sensitive to sinulariolide treatment. Treatment with sinulariolide induced HA22T cell apoptosis, as demonstrated by flow cytometry, TUNEL/DAPI stain and Annexin V/PI stain analyses. The flow cytometric results indicated that sinulariolide induced both early and late apoptosis (<xref ref-type="fig" rid="molecules-18-10146-f002">Figure 2</xref>A).</p>
        <p>Induction of apoptosis is directed by intrinsic or extrinsic pathways [<xref ref-type="bibr" rid="B6-molecules-18-10146">6</xref>,<xref ref-type="bibr" rid="B7-molecules-18-10146">7</xref>,<xref ref-type="bibr" rid="B20-molecules-18-10146">20</xref>]. Mitochondria play an important role in the initiation of intrinsic pathway with stress. Recent studies suggested endoplasmic reticulum (ER) could also initiate apoptotic cascade in response to stress [<xref ref-type="bibr" rid="B20-molecules-18-10146">20</xref>,<xref ref-type="bibr" rid="B21-molecules-18-10146">21</xref>]. In response to stress, pro-apoptotic proteins Bid, Bax and Bak are activated, while anti-apoptotic proteins like Bcl-xL, Bcl-2 and Mcl-1 are suppressed. These changes in apoptotic-related proteins and increased ratio of Bax/Bcl-2 result in alteration of mitochondrial membrane potentials, and cytochrome <italic>c</italic> and apoptosis-inducing factor (AIF) are released from the mitochondrial inter-membrane spaces into cytosol [<xref ref-type="bibr" rid="B11-molecules-18-10146">11</xref>]. The release of cytochrome <italic>c</italic> from mitochondrial inter-membrane spaces initiates further caspase pathway by binding to Apaf1 and caspase-9, forming apoptosome, and leads to the activation of downstream effector caspase-3 [<xref ref-type="bibr" rid="B22-molecules-18-10146">22</xref>,<xref ref-type="bibr" rid="B23-molecules-18-10146">23</xref>]. The activated caspase-3 then inactivated poly-(ADP-ribose) polymerase (PARP) through caspase cleavage [<xref ref-type="bibr" rid="B11-molecules-18-10146">11</xref>]. In this study, sinulariolide suppressed anti-apoptotic factors Bcl-2, Bcl-xL and Mcl-1, and promoted pro-apoptotic factors Bad and Bax (<xref ref-type="fig" rid="molecules-18-10146-f004">Figure 4</xref>). The change in mitochondrial membrane potential was also observed after sinulariolide treatment, leading to cytochrome <italic>c</italic> and AIF release. The levels of activated caspase-3 and caspase-9, and cleaved PARP were also increased in a sinulariolide concentration-dependent manner (<xref ref-type="fig" rid="molecules-18-10146-f003">Figure 3</xref>). The present data supported that sinulariolide can induce apoptosis of HA22T cells through the activation of mitochondria-related apoptotic pathway.</p>
        <p>The ER is a central organelle responsible for regulating intracellular Ca<sup>2</sup><sup>+</sup> homeostasis, protein folding, protein synthesis and lipid synthesis [<xref ref-type="bibr" rid="B10-molecules-18-10146">10</xref>,<xref ref-type="bibr" rid="B24-molecules-18-10146">24</xref>]. The ER is known to respond to various stressors and slows the protein folding process. In the present study, ER stress is also observed to involve in the apoptotic events after sinulariolide treatment in HCC cells [<xref ref-type="bibr" rid="B8-molecules-18-10146">8</xref>,<xref ref-type="bibr" rid="B24-molecules-18-10146">24</xref>]. The activation of UPR critically requires glucose-regulated protein 78 (GRP78) to regulate three ER-resident transmembrane sensors, inositol-requiring enzyme 1 alpha (IRE1&#x3B1;), RNA-dependent protein kinase (PKR)-like ER kinase (PERK), and activating transcription factor 6 (ATF6). Under ER stress, these sensors trigger responses toward restoration of normal ER function or apoptosis [<xref ref-type="bibr" rid="B25-molecules-18-10146">25</xref>]. Among these, IRE1&#x3B1; is the most conserved UPR [<xref ref-type="bibr" rid="B26-molecules-18-10146">26</xref>]. </p>
        <p>To verify the involvement of ER stress in the sinulariolide-induced apoptosis, we further analyzed UPR sensors, including activating transcription factor 4 (ATF4), a downstream effector of the PERK-eIF2&#x3B1; signal pathway. ATF4 translocates into nucleus, leading to further downstream CHOP gene expression. CHOP is identified to be one of the proteins that mediate ER stress-induced apoptosis [<xref ref-type="bibr" rid="B27-molecules-18-10146">27</xref>,<xref ref-type="bibr" rid="B28-molecules-18-10146">28</xref>]. In the present study, the expression of ATF4 and CHOP were significantly increased after sinulariolide treatment (<xref ref-type="fig" rid="molecules-18-10146-f005">Figure 5</xref>), indicating the role of ATF4 in the regulation of CHOP expression through PERK-eIF2&#x3B1; signal pathway following treatment of sinulariolide.</p>
        <p>We also found an increased expression of ATF6, another UPR sensor, after treating sinulariolide (<xref ref-type="fig" rid="molecules-18-10146-f004">Figure 4</xref>A). ATF6 is another UPR sensor that is induced through ER stress. Activated ATF6 is a transcription factor that regulates ER chaperones, X box-binding protein 1 (XBP1) [<xref ref-type="bibr" rid="B29-molecules-18-10146">29</xref>] and CHOP expression [<xref ref-type="bibr" rid="B30-molecules-18-10146">30</xref>,<xref ref-type="bibr" rid="B31-molecules-18-10146">31</xref>]. In the present study, we also found increased expression of fragmented ATF6 by immunoblotting (<xref ref-type="fig" rid="molecules-18-10146-f005">Figure 5</xref>), indicating the role of ATF6 in the regulation of CHOP expression in response to ER stress induced by sinulariolide treatment.</p>
        <p>To confirm the involvement of PERK-eIF2&#x3B1; signal pathway in the ATF4 regulated CHOP expression, we pre-treated hepatoma cells with an ER stress inhibitor, salubrinal, that targeted specific phosphatase of eIF2&#x3B1;, blocking the dephosphorylation of p-eIF2&#x3B1; [<xref ref-type="bibr" rid="B32-molecules-18-10146">32</xref>]. The result showed that the degree of cell death induced by sinulariolide was partially reversed by salubrinal pre-treatment (<xref ref-type="fig" rid="molecules-18-10146-f006">Figure 6</xref>). In our current study, we found that PERK/eIF2&#x3B1;/ATF4/CHOP signal pathway was not the only pathway involved in the sinulariolide induced cell apoptosis. The ATF6/CHOP pathway was also involved. Thus, inhibition of p-eIF2&#x3B1; dephysphorylation by salubrinal could only partially abrogate sinulariolide induced cell apoptosis by around 24%. However, the expressions of IRE1&#x3B1; and caspase-12 were not changed following sinulariolide treatment.</p>
        <p>In conclusion, it is suggested that sinulariolide is capable of inducing HCC cell apoptosis via both mitochondrial-related apoptotic pathway and ER-stress induced apoptotic pathway. Further study is indicated to determine the cytotoxic effect of sinulariolide to hepatoma <italic>in vivo</italic>. </p>
      </sec>
    </sec>
    <sec sec-type="methods">
      <title>3. Experimental</title>
      <sec>
        <title>3.1. Materials</title>
        <p>Rabbit anti-human poly ADP-ribose polymerase-1 (PARP-1), eIF2-&#x3B1;, and glucose-related protein 78 (GRP78), glucose-related proteins 94 (GRP94) antibodies were obtained from Epitomics (Burlingame, CA, USA). Rabbit anti-human cleaved-ATF6 and ATF4 antibodies were obtained from ProteinTech Group (Chicago, IL, USA). Rabbit anti-human pro-casapse-3, pro-caspase-8, pro-caspase-9, cleaved caspase-3, cleaved caspase-9, Bax, Bcl-xL, Bcl-2, Bad, p-Bad, PERK, p-PERK, p-eIF2-&#x3B1;, calreticulin (CALR) cytochrome <italic>c</italic> and GAPDH antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). Dimethyl sulfoxide (DMSO), 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Protease inhibitor cocktail, salubrinal (eIF2-&#x3B1; inhibitor) and rabbit anti-human &#x3B2;-actin antibodies were obtained from Sigma (St. Louis, MO, USA). PVDF (polyvinylidenedifluoride) membranes and goat anti-rabbit and horseradish peroxidase conjugated IgG were obtained from Millipore (Bellerica, MA, USA). Mitochondria/cytosol fractionation kit was obtained from BioSource International (Camarillo, CA, USA). Chemiliminescent HRP substrate was purchased from Pierce (Rockford, IL, USA). Annexin V&#x2013;FITC Apoptosis Detection kit was obtained from Pharmingen (San Diego, CA, USA). JC-1 (5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolcarbocyanine iodide) fluorescent kit was obtained from Biotium (Hayward, CA, USA).DAPI fluorescent kit and TUNEL fluorescent kit were obtained from Promega (Madison, WI, USA). Sinulariolide was extracted from cultured soft coral <italic>Sinularia</italic> <italic>flexibilis</italic>, following the protocol described by Su <italic>et al</italic>. [<xref ref-type="bibr" rid="B17-molecules-18-10146">17</xref>], and dissolved in DMSO<italic>.</italic></p>
      </sec>
      <sec>
        <title>3.2. Cell Culture and MTT Assay</title>
        <p>HepG2, HepG3, Huh7 and HA22T HCC cell lines were purchased from Food Industry Research and Development Institute (Hsinchu, Taiwan) and were cultured in DMEM (Biowest, Nuaill&#xE9;, France) containing 4 mM L-glutamine, 1 mM sodium pyruvate, 100 &#x3BC;g/mL streptomycin, 100 U/mL penicillin and 10% (v/v) fetal bovine serum, in a 37 &#xB0;C humidified atmosphere with 5% CO<sub>2</sub>. Four HCC cell lines were used to determine the cytotoxic effect of sinulariolide on HCC cells. Each cell line was treated with various concentrations of sinulariolide (2, 4, 8, 10 &#x3BC;g/mL) and harvested after incubation for 24 h. The cell viability of HCC cells after sinulariolide treatment was examined by colorimetric MTT assay, as described in our previous study [<xref ref-type="bibr" rid="B33-molecules-18-10146">33</xref>]. HCC cells were seeded on 24-well culture plates at a density of 1 &#xD7; 10<sup>5</sup> cells/well. After the addition of 2&#x2013;10 &#x3BC;g/mL sinulariolide for 24 h, 50 &#x3BC;L of MTT solution (1 mg/mL in PBS) was added to each well. Cells treated with DMSO without sinulariolide were used as blank control. The plates were then incubated at 37 &#xB0;C for 4 h. Then cells were lysed with 200 &#x3BC;L DMSO. The optimal density (O.D) was measured at 595 nm by a microtiter ELISA reader (Bio-Rad, Hercules, CA) with DMSO as the blank. All the experiments were repeated three times.</p>
      </sec>
      <sec>
        <title>3.3. Colony Formation Assay</title>
        <p>Colony formation assay was performed following the previous study [<xref ref-type="bibr" rid="B34-molecules-18-10146">34</xref>]. HA22T (2000 cells/well) and HepG2 (2000 cells/well) cells were seeded in 24-well plates. After 24 h, cells were treated with various concentrations (2, 4, 8 and 10 &#x3BC;g/mL final concentration) of sinulariolide in 2 mL of serum complete media. After culture for 10 days, media were removed and colonies were washed with PBS. The colonies were fixed with methanol for 15 min and stained with 0.15% crystal violet for 10 min. The colonies were counted and scanned with a high-resolution scanner Scan Maker 9800XL (MiCROTEK, Hsinchu, Taiwan). The cells observed with no connection in between is calculated as one colony. Regarding the structure formed by the connection of cells, we estimated the shape and the size of it to figure out its cell count (for overlapping ones we calculate them as one cell). </p>
      </sec>
      <sec>
        <title>3.4. Quantitative Detection of Apoptosis by Flow Cytometry</title>
        <p>To determine the apoptosis induced by sinulariolide in HA22T cells, the annexin V&#x2013;FITC Apoptosis Detection kit was used following the protocol described in the previous study [<xref ref-type="bibr" rid="B33-molecules-18-10146">33</xref>]. A total of 1 &#xD7; 10<sup>6</sup> cells were seeded onto 5 cm petri-dish and treated with various concentrations of sinulariolide or 0.1% DMSO for 24 h, and cells were subsequently collected and fixed in 70% cold ethanol at 4 &#xB0;C overnight. After washing, the cells were stained with annexin V-FITC and propidium iodide (PI) for 30 min at 37 &#xB0;C following the protocol provided by the manufacturer. FACScan flow cytometer and Cell-Quest software (Becton-Dickinson, Mansfield, MA, USA) were used to analyze the apoptotic cells. </p>
      </sec>
      <sec>
        <title>3.5. TUNEL Assay and DAPI Staining</title>
        <p>HA22T cells (1 &#xD7; 10<sup>5</sup> cells/well) cultured in 12-well plates were treated with 4, 8, and 10 &#x3BC;g/mL sinulariolide for 24 h, while adding DMSO for the control. Cells in each concentration and control were fixed with ice-cold 4% paraformaldehyde in PBS solution for 15 min, washed with PBS and then stained with 2 &#x3BC;g/mL DAPI for 20 min at 37 &#xB0;C. TUNEL was performed according to the manufacturer&#x2019;s manual for DeadEnd&#x2122; Fluorometric TUNEL System (Promega). The cells were photographed under a fluorescence microscopy (Olympus IX71 CTS, Chinetek Scientific, Hong Kong, China).</p>
      </sec>
      <sec>
        <title>3.6. JC-1 Staining</title>
        <p>Following treatment with different concentrations of sinulariolide, the changes in the mitochondrial membrane potential (&#x394;&#x3A8;m) were assessed, using cationic dye JC-1 for staining. In cells with healthy mitochondria, JC-1 accumulated in mitochondria, indicating red fluorescence emission (560 nm). As mitochondrial membrane potentials changed, JC-1 uptake was distributed in cytoplasm, indicating green fluorescence emission (530 nm). HA22T cells were pretreated with sinulariolide, and incubated with 10 mg/mL JC-1 at 37 &#xB0;C in the dark for 30 min. Cells were washed twice with serum-free medium and observed under fluorescence microscopy (Olympus IX71 CTS).</p>
      </sec>
      <sec>
        <title>3.7. Caspase-3 and Caspase-9 Activity Assay</title>
        <p>Caspase-3 and caspase-9 fluorescence assay kits were purchased from Cell Signaling Technology. For caspase-3 activity measurement, cells were collected and resuspended in lysis buffer on ice for 30 minutes, followed by centrifugation at 12,000 rpm at 4 &#xB0;C to obtain supernatant. Reaction mixture and caspase-3 substrate (Ac-DEVD-AMC) were added into cell supernatant and incubated at 37 &#xB0;C for 2 h. The caspase-3 activity was measured by a fluorometer (Turner Biosystem, Promega), with fluorescence excitation wavelength of 350 nm and emission wavelength of 420 nm. For caspase-9 activity measurement, cells were resuspended in lysis buffer on ice for 30 min, followed by centrifugation at 12,000 rpm at 4 &#xB0;C to obtain supernatant. Reaction mixture and caspase-9 substrate (Ac-LEHD-AFC) were added into cell supernatant and incubated at 37 &#xB0;C for 2 h. The caspase-9 activity was measured by fluorometer (Turner Biosystem), with fluorescence excitation wavelength of 400 nm and emission wavelength of 505 nm. </p>
      </sec>
      <sec>
        <title>3.8. Mitochondria and Cytosol Fractionation</title>
        <p>The mitochondria and cytosol fractions were separated with commercial mitochondria/cytosol fractionation kit (BioSource International, Camarillo, CA, USA), following the methods previously reported [<xref ref-type="bibr" rid="B19-molecules-18-10146">19</xref>].</p>
      </sec>
      <sec>
        <title>3.9. Western Blot Analysis</title>
        <p>Western blot analysis was performed following the methods previously reported [<xref ref-type="bibr" rid="B35-molecules-18-10146">35</xref>]. The treated samples and the control samples (25 &#x3BC;g) were separated by 12.5% SDS-PAGE, and then transferred onto PVDF membrane for 1.5 h at 400 mA using Transphor TE 62 (Hoeffer) and then proteins transfer checked by staining with Ponceau S solution. The membranes were incubated with 5% dehydrated skim milk to block nonspecific protein bindings, and then incubated with primary antibodies at 4 &#xB0;C overnight. The primary anti-human PARP-1, pro-caspase-3, cleaved-caspase-3, pro-caspase-9, cleaved-caspase-9, pro-caspase-8, pro-caspase-12, cytochorme <italic>c</italic>, Bax, Bad, p-Bad, Bcl-2, Bxl-xL, Mcl-1, AIF, CALR, eIF2&#x3B1;, p- eIF2&#x3B1;, IRE1&#x3B1;, PERK, p-PERK, CHOP, ATF4, cleaved-ATF6 and &#x3B2;-actin antibodies were used. The second antibodies (horseradish peroxidase conjugate goat anti-rabbit, 1:5,000 in blocking solution) were added and incubated for 2 h at 4 &#xB0;C and then visualized using chemiluminesence (Pierce). The western blot data were quantified using Image J software.</p>
      </sec>
      <sec>
        <title>3.10. Statistical Analysis</title>
        <p>Data of MTT assay, colony formation and flow cytometric analysis were pooled from three independent experiments. The results were expressed as mean &#xB1; standard error of mean (SEM). Data acquisition and analysis of variance (ANOVA) was carried out by the Tukey-Kramer test, using GraphPadInStat 3 software (San Diego, CA, USA) [<xref ref-type="bibr" rid="B16-molecules-18-10146">16</xref>].</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>4. Conclusions</title>
      <p>In conclusion, our results demonstrated that sinulariolide may have potential selective cytotoxic effects towards HA22T cells by mediation through the induction of cell apoptosis. Mitochondrial-related apoptosis and PERK/eIF2&#x3B1;/ATF4/CHOP signal pathway were induced by sinulariolide (<xref ref-type="fig" rid="molecules-18-10146-f007">Figure 7</xref>). The findings in our current study also benefit the HCC pharmaceutical development in the clinical setting. Hence, further evaluation of the anti-HCC effect of sinulariolide is needed to determine the <italic>in vivo</italic> efficacy and pharmacokinetic effects of this naturally extracted compound.</p>
      <fig id="molecules-18-10146-f007" position="float">
        <label>Figure 7</label>
        <caption>
          <p>Illustration of how sinulariolide induces cellular apoptosis through mitochondrial-related apoptosis and PERK/eIF2&#x3B1;/ATF4/CHOP pathway on HA22T cells.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-18-10146-g007.tif"/>
      </fig>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by grants from the National Science Council (NSC 101-2313-B-276-002 and NSC 102-2313-B-276-002-MY3).</p>
    </ack>
	<notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molecules-18-10146">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parkin</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Bray</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ferlay</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pisani</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Global cancer statistics, 2002</article-title>
          <source>CA Cancer J. Clin.</source>
          <year>2005</year>
          <volume>55</volume>
          <fpage>74</fpage>
          <lpage>108</lpage>
          <pub-id pub-id-type="doi">10.3322/canjclin.55.2.74</pub-id>
        </citation>
      </ref>
      <ref id="B2-molecules-18-10146">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Serag</surname>
              <given-names>H.B.</given-names>
            </name>
            <name>
              <surname>Rudolph</surname>
              <given-names>K.L.</given-names>
            </name>
          </person-group>
          <article-title>Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis</article-title>
          <source>Gastroenterology</source>
          <year>2007</year>
          <volume>132</volume>
          <fpage>2557</fpage>
          <lpage>2576</lpage>
          <pub-id pub-id-type="doi">10.1053/j.gastro.2007.04.061</pub-id>
        </citation>
      </ref>
      <ref id="B3-molecules-18-10146">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Czaja</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Current management strategies for hepatocellular carcinoma</article-title>
          <source>Minerva Gastroenterol. Dietol.</source>
          <year>2013</year>
          <volume>59</volume>
          <fpage>143</fpage>
          <lpage>159</lpage>
        </citation>
      </ref>
      <ref id="B4-molecules-18-10146">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez-Martin</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>de la Fuente-Fernandez</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Corbaton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Gisbert</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn&#x2019;s disease</article-title>
          <source>Gastroenterol. Hepatol.</source>
          <year>2011</year>
          <volume>34</volume>
          <fpage>16</fpage>
          <lpage>19</lpage>
        </citation>
      </ref>
      <ref id="B5-molecules-18-10146">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Michael</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Butler-Manuel</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Advances in the treatment of ovarian cancer: A potential role of antiinflammatory phytochemicals</article-title>
          <source>Discov. Med.</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>7</fpage>
          <lpage>17</lpage>
        </citation>
      </ref>
      <ref id="B6-molecules-18-10146">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Denicourt</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Dowdy</surname>
              <given-names>S.F.</given-names>
            </name>
          </person-group>
          <article-title>Medicine. Targeting apoptotic pathways in cancer cells</article-title>
          <source>Science</source>
          <year>2004</year>
          <volume>305</volume>
          <fpage>1411</fpage>
          <lpage>1413</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1102974</pub-id>
        </citation>
      </ref>
      <ref id="B7-molecules-18-10146">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wajant</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>The Fas signaling pathway: More than a paradigm</article-title>
          <source>Science</source>
          <year>2002</year>
          <volume>296</volume>
          <fpage>1635</fpage>
          <lpage>1636</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1071553</pub-id>
        </citation>
      </ref>
      <ref id="B8-molecules-18-10146">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ron</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Signal integration in the endoplasmic reticulum unfolded protein response</article-title>
          <source>Nat. Rev. Mol. Cell. Biol</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>519</fpage>
          <lpage>529</lpage>
          <pub-id pub-id-type="doi">10.1038/nrm2199</pub-id>
        </citation>
      </ref>
      <ref id="B9-molecules-18-10146">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bugger</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Abel</surname>
              <given-names>E.D.</given-names>
            </name>
          </person-group>
          <article-title>Rodent models of diabetic cardiomyopathy</article-title>
          <source>Dis. Model. Mech</source>
          <year>2009</year>
          <volume>2</volume>
          <fpage>454</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="doi">10.1242/dmm.001941</pub-id>
        </citation>
      </ref>
      <ref id="B10-molecules-18-10146">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Ellerby</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Bredesen</surname>
              <given-names>D.E.</given-names>
            </name>
          </person-group>
          <article-title>Coupling endoplasmic reticulum stress to the cell death program</article-title>
          <source>Cell. Death Differ.</source>
          <year>2004</year>
          <volume>11</volume>
          <fpage>372</fpage>
          <lpage>380</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.cdd.4401378</pub-id>
        </citation>
      </ref>
      <ref id="B11-molecules-18-10146">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicholson</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Thornberry</surname>
              <given-names>N.A.</given-names>
            </name>
          </person-group>
          <article-title>Apoptosis. Life and death decisions</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>299</volume>
          <fpage>214</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1081274</pub-id>
        </citation>
      </ref>
      <ref id="B12-molecules-18-10146">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Green</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondria and apoptosis</article-title>
          <source>Science</source>
          <year>1998</year>
          <volume>281</volume>
          <fpage>1309</fpage>
          <lpage>1312</lpage>
          <pub-id pub-id-type="doi">10.1126/science.281.5381.1309</pub-id>
        </citation>
      </ref>
      <ref id="B13-molecules-18-10146">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.C.</given-names>
            </name>
            <name>
              <surname>El-Shazly</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>Y.C.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Tsao</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Yen</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>W.B.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>Y.D.</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>Y.T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>5-Episinuleptolide acetate, a norcembranoidal diterpene from the formosan soft coral Sinularia sp., Induces leukemia cell apoptosis through Hsp90 inhibition</article-title>
          <source>Molecules</source>
          <year>2013</year>
          <volume>18</volume>
          <fpage>2924</fpage>
          <lpage>2933</lpage>
          <pub-id pub-id-type="doi">10.3390/molecules18032924</pub-id>
        </citation>
      </ref>
      <ref id="B14-molecules-18-10146">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>C.I.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>R.Y.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.J.</given-names>
            </name>
          </person-group>
          <article-title>Proteomic profiling of the 11-dehydrosinulariolide-treated oral carcinoma cells Ca9&#x2013;22: Effects on the cell apoptosis through mitochondrial-related and ER stress pathway</article-title>
          <source>J. Proteomics</source>
          <year>2012</year>
          <volume>75</volume>
          <fpage>5578</fpage>
          <lpage>5589</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jprot.2012.07.037</pub-id>
        </citation>
      </ref>
      <ref id="B15-molecules-18-10146">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>W.I.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.J.</given-names>
            </name>
          </person-group>
          <article-title>An investigation into the cytotoxic effects of 13-acetoxysarcocrassolide from the soft coral sarcophyton crassocaule on bladder cancer cells</article-title>
          <source>Mar. Drugs</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>2622</fpage>
          <lpage>2642</lpage>
          <pub-id pub-id-type="doi">10.3390/md9122622</pub-id>
        </citation>
      </ref>
      <ref id="B16-molecules-18-10146">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Z.J.</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>W.I.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.J.</given-names>
            </name>
          </person-group>
          <article-title>Proteomic investigation of anti-tumor activities exerted by sinularin against A2058 melanoma cells</article-title>
          <source>Electrophoresis</source>
          <year>2012</year>
          <volume>33</volume>
          <fpage>1139</fpage>
          <lpage>1152</lpage>
          <pub-id pub-id-type="doi">10.1002/elps.201100462</pub-id>
        </citation>
      </ref>
      <ref id="B17-molecules-18-10146">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y.F.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>H.C.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>T.Y.</given-names>
            </name>
            <name>
              <surname>Sheu</surname>
              <given-names>J.H.</given-names>
            </name>
          </person-group>
          <article-title>Oxygenated cembranoids from the cultured and wild-type soft corals Sinularia flexibilis</article-title>
          <source>Chem. Pharm. Bull.</source>
          <year>2009</year>
          <volume>57</volume>
          <fpage>1189</fpage>
          <lpage>1192</lpage>
          <pub-id pub-id-type="doi">10.1248/cpb.57.1189</pub-id>
        </citation>
      </ref>
      <ref id="B18-molecules-18-10146">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aceret</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Coll</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Uchio</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sammarco</surname>
              <given-names>P.W.</given-names>
            </name>
          </person-group>
          <article-title>Antimicrobial activity of the diterpenes flexibilide and sinulariolide derived from <italic>Sinularia flexibilis</italic> Quoy and Gaimard 1833 (Coelenterata: Alcyonacea, Octocorallia)</article-title>
          <source>Comp. Biochem. Physiol. C</source>
          <year>1998</year>
          <volume>120</volume>
          <fpage>121</fpage>
          <lpage>126</lpage>
        </citation>
      </ref>
      <ref id="B19-molecules-18-10146">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neoh</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>R.Y.</given-names>
            </name>
            <name>
              <surname>Din</surname>
              <given-names>Z.H.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.K.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Weng</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.J.</given-names>
            </name>
          </person-group>
          <article-title>Induction of apoptosis by sinulariolide from soft coral through mitochondrial-related and p38MAPK pathways on human bladder carcinoma cells</article-title>
          <source>Mar. Drugs</source>
          <year>2012</year>
          <volume>10</volume>
          <fpage>2893</fpage>
          <lpage>2911</lpage>
          <pub-id pub-id-type="doi">10.3390/md10122893</pub-id>
        </citation>
      </ref>
      <ref id="B20-molecules-18-10146">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matthews</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Newbold</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Johnstone</surname>
              <given-names>R.W.</given-names>
            </name>
          </person-group>
          <article-title>Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activity</article-title>
          <source>Adv. Cancer Res.</source>
          <year>2012</year>
          <volume>116</volume>
          <fpage>165</fpage>
          <lpage>197</lpage>
        </citation>
      </ref>
      <ref id="B21-molecules-18-10146">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zielinski</surname>
              <given-names>R.R.</given-names>
            </name>
            <name>
              <surname>Eigl</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Chi</surname>
              <given-names>K.N.</given-names>
            </name>
          </person-group>
          <article-title>Targeting the apoptosis pathway in prostate cancer</article-title>
          <source>Cancer J.</source>
          <year>2013</year>
          <volume>19</volume>
          <fpage>79</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1097/PPO.0b013e3182801cf7</pub-id>
        </citation>
      </ref>
      <ref id="B22-molecules-18-10146">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez-Girones</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Moncunill-Massaguer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Iglesias-Serret</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cosialls</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Perez-Perarnau</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Palmeri</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Rubio-Patino</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Villunger</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pons</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts</article-title>
          <source>Apoptosis</source>
          <year>2013</year>
          <volume>18</volume>
          <fpage>1008</fpage>
          <lpage>1016</lpage>
          <pub-id pub-id-type="doi">10.1007/s10495-013-0850-6</pub-id>
        </citation>
      </ref>
      <ref id="B23-molecules-18-10146">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaparou</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Choumerianou</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Perdikogianni</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Martimianaki</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kalmanti</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Stiakaki</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features</article-title>
          <source>Genet. Mol. Biol.</source>
          <year>2013</year>
          <volume>36</volume>
          <fpage>7</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1590/S1415-47572013005000003</pub-id>
        </citation>
      </ref>
      <ref id="B24-molecules-18-10146">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyce</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Cellular response to endoplasmic reticulum stress: A matter of life or death</article-title>
          <source>Cell. Death Differ.</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>363</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.cdd.4401817</pub-id>
        </citation>
      </ref>
      <ref id="B25-molecules-18-10146">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Szegezdi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Logue</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Gorman</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Samali</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Mediators of endoplasmic reticulum stress-induced apoptosis</article-title>
          <source>EMBO Rep.</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>880</fpage>
          <lpage>885</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.embor.7400779</pub-id>
        </citation>
      </ref>
      <ref id="B26-molecules-18-10146">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oono</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yoneda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Manabe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yamagishi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hitomi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Miyata</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Imaizumi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Katayama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tohyama</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>JAB1 participates in unfolded protein responses by association and dissociation with IRE1</article-title>
          <source>Neurochem. Int.</source>
          <year>2004</year>
          <volume>45</volume>
          <fpage>765</fpage>
          <lpage>772</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuint.2004.01.003</pub-id>
        </citation>
      </ref>
      <ref id="B27-molecules-18-10146">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities</article-title>
          <source>Nat. Rev. Drug Discov.</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>1013</fpage>
          <lpage>1030</lpage>
          <pub-id pub-id-type="doi">10.1038/nrd2755</pub-id>
        </citation>
      </ref>
      <ref id="B28-molecules-18-10146">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oyadomari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Roles of CHOP/GADD153 in endoplasmic reticulum stress</article-title>
          <source>Cell. Death Differ.</source>
          <year>2004</year>
          <volume>11</volume>
          <fpage>381</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.cdd.4401373</pub-id>
        </citation>
      </ref>
      <ref id="B29-molecules-18-10146">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1</article-title>
          <source>Dev. Cell.</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>365</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2007.07.018</pub-id>
        </citation>
      </ref>
      <ref id="B30-molecules-18-10146">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schroder</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>The mammalian unfolded protein response</article-title>
          <source>Annu. Rev. Biochem.</source>
          <year>2005</year>
          <volume>74</volume>
          <fpage>739</fpage>
          <lpage>789</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.biochem.73.011303.074134</pub-id>
        </citation>
      </ref>
      <ref id="B31-molecules-18-10146">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takayanagi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tsukada</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Gene regulatory network of unfolded protein response genes in endoplasmic reticulum stress</article-title>
          <source>Cell. Stress Chaperones</source>
          <year>2013</year>
          <volume>18</volume>
          <fpage>11</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1007/s12192-012-0351-5</pub-id>
        </citation>
      </ref>
      <ref id="B32-molecules-18-10146">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyce</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bryant</surname>
              <given-names>K.F.</given-names>
            </name>
            <name>
              <surname>Jousse</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Harding</surname>
              <given-names>H.P.</given-names>
            </name>
            <name>
              <surname>Scheuner</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Coen</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Ron</surname>
              <given-names>D.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>307</volume>
          <fpage>935</fpage>
          <lpage>939</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1101902</pub-id>
        </citation>
      </ref>
      <ref id="B33-molecules-18-10146">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y.T.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.J.</given-names>
            </name>
          </person-group>
          <article-title>Induction of apoptosis by 11-dehydrosinulariolide via mitochondrial dysregulation and ER stress pathways in human melanoma cells</article-title>
          <source>Mar. Drugs</source>
          <year>2012</year>
          <volume>10</volume>
          <fpage>1883</fpage>
          <lpage>1898</lpage>
          <pub-id pub-id-type="doi">10.3390/md10081883</pub-id>
        </citation>
      </ref>
      <ref id="B34-molecules-18-10146">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiang</surname>
              <given-names>W.F.</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>T.Z.</given-names>
            </name>
            <name>
              <surname>Hour</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H.R.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>C.Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma</article-title>
          <source>Oral Oncol.</source>
          <year>2013</year>
          <volume>49</volume>
          <fpage>534</fpage>
          <lpage>541</lpage>
          <pub-id pub-id-type="doi">10.1016/j.oraloncology.2013.01.003</pub-id>
        </citation>
      </ref>
      <ref id="B35-molecules-18-10146">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ho</surname>
              <given-names>K.Y.</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>T.S.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>K.F.</given-names>
            </name>
            <name>
              <surname>Chai</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W.T.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth</article-title>
          <source>Int. J. Mol. Sci.</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>14439</fpage>
          <lpage>14459</lpage>
          <pub-id pub-id-type="doi">10.3390/ijms140714439</pub-id>
        </citation>
      </ref>
    </ref-list>
	<fn-group>
	 <fn>
	  <p><italic>Sample Availability</italic>: Sinulariolide is available from Dr. Jui-Hsin Su.</p>
	 </fn>
	</fn-group> 
  </back>
</article>
